<DOC>
	<DOCNO>NCT00002271</DOCNO>
	<brief_summary>To characterize pharmacokinetics orally administer 3'-deoxy-3'-fluorothymidine ( FLT ) , liquid formulation , single dos asymptomatic HIV-infected patient assess safety tolerance single oral dos FLT .</brief_summary>
	<brief_title>An Ascending , Single Oral Dose Pharmacokinetic Study 3'-Deoxy-3'-Fluorothymidine ( FLT ) Asymptomatic Human Immunodeficiency Virus ( HIV ) -Infected Subjects</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Alovudine</mesh_term>
	<mesh_term>Dideoxynucleosides</mesh_term>
	<criteria>Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Oral candida infection document morphology response antifungal therapy within 2 month prior study entry . Temperature &gt; 37.8 degree Centigrade . Malignancy cutaneous basal cell carcinoma cervical carcinoma situ . Significant chronic underlie medical illness would prevent continuous participation clinical trial . Concurrent Medication : Excluded : Patients follow exclude : Significant chronic underlie medical illness would prevent continuous participation clinical trial . Unwilling sign inform consent . Intolerant zidovudine ( AZT ) . Oral hairy leukoplakia time prior study entry . Prior Medication : Excluded within 7 day study entry : Antiretroviral drug . Immunomodulators . Excluded within 30 day study entry : Any investigational drug . Patients follow : HIV seropositivity license ELISA test , confirm Western Blot analysis . No symptom define : 1 . Normal neurological exam . 2 . Absence follow : Unintentional weight loss great 10 pound 10 percent usual body weight within 2 month prior study entry . Unexplained temperature &gt; 37.8 C 5 consecutive day 10 day 30 day period one month prior expect study entry . Unexplained diarrhea define = &gt; 3 liquid stool per day persist &gt; 7 day within 2 month prior expect study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1991</verification_date>
	<keyword>Thymidine</keyword>
	<keyword>Nucleosides</keyword>
	<keyword>Antiviral Agents</keyword>
</DOC>